Veracyte partners with J&J on development of lung cancer test
The deal, with J&J Innovation and the drugmaker's lung cancer initiative, includes a $5 million upfront payment and up to $15 million in milestones.
field of injury
The deal, with J&J Innovation and the drugmaker's lung cancer initiative, includes a $5 million upfront payment and up to $15 million in milestones.